» Articles » PMID: 28935596

Animal Models for Evaluation of Oral Delivery of Biopharmaceuticals

Overview
Specialty Pharmacology
Date 2017 Sep 23
PMID 28935596
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Biopharmaceuticals are increasingly important for patients and the pharmaceutical industry due to their ability to treat and, in some cases, even cure chronic and potentially life-threatening diseases. Most biopharmaceuticals are administered by injection, but intensive focus on development of systems for oral delivery of biopharmaceuticals may result in new treatment modalities to increase the patient compliance and reduce product cost. In the preclinical development phase, use of experimental animal models is essential for evaluation of new formulation designs. In general, the limited oral bioavailability of biopharmaceuticals, of just a few percent, is expected, and therefore, the animal models and the experimental settings must be chosen with utmost care. More knowledge and focus on this topic is highly needed, despite experience from the numerous studies evaluating animal models for oral drug delivery of small molecule drugs. This review highlights and discusses pros and cons of the most currently used animal models and settings. Additionally, it also looks into the influence of anesthetics and sampling methods for evaluation of drug delivery systems for oral delivery of biopharmaceuticals primarily with examples on insulin.

Citing Articles

Novel Triazeneindole Antibiotics: Synthesis and Hit-to-Lead Optimization.

Sorokin B, Filimonova A, Emelianova A, Kublitski V, Gvozd A, Shmygarev V Int J Mol Sci. 2025; 26(5).

PMID: 40076499 PMC: 11899342. DOI: 10.3390/ijms26051870.


Hesperetin but not ellagic acid increases myosin heavy chain expression and cell fusion in C2C12 myoblasts in the presence of oxidative stress.

Cuijpers I, Dohmen C, Bouwman F, Troost F, Sthijns M Front Nutr. 2024; 11:1377071.

PMID: 39285862 PMC: 11402829. DOI: 10.3389/fnut.2024.1377071.


A systematic review of ultrasound-mediated drug delivery to the eye and critical insights to facilitate a timely path to the clinic.

Rad I, Chapman L, Tupally K, Veidt M, Al-Sadiq H, Sullivan R Theranostics. 2023; 13(11):3582-3638.

PMID: 37441595 PMC: 10334839. DOI: 10.7150/thno.82884.


Nonviral delivery systems for antisense oligonucleotide therapeutics.

Huang S, Hao X, Li Y, Wu J, Xiang D, Luo S Biomater Res. 2022; 26(1):49.

PMID: 36180936 PMC: 9523189. DOI: 10.1186/s40824-022-00292-4.


Barriers to the Intestinal Absorption of Four Insulin-Loaded Arginine-Rich Nanoparticles in Human and Rat.

Lundquist P, Khodus G, Niu Z, Thwala L, McCartney F, Simoff I ACS Nano. 2022; 16(9):14210-14229.

PMID: 35998570 PMC: 9527806. DOI: 10.1021/acsnano.2c04330.